Two medical associations are throwing their support behind a lawsuit challenging the constitutionality of the medical marijuana ballot initiative that Mississippi voters overwhelmingly approved in November, arguing that it creates “risks to public health” and places a “burden” on physicians. The American Medical Association (AMA) and its state affiliate,... Read more
Two medical associations are throwing their support behind a lawsuit challenging the constitutionality of the medical marijuana ballot initiative that Mississippi voters overwhelmingly approved in November, arguing that it creates “risks to public health” and places a “burden” on physicians. The American Medical Association (AMA) and its state affiliate,... Read more
Two medical associations are throwing their support behind a lawsuit challenging the constitutionality of the medical marijuana ballot initiative that Mississippi voters overwhelmingly approved in November, arguing that it creates “risks to public health” and places a “burden” on physicians. The American Medical Association (AMA) and its state affiliate,... Read more
Are These Marijuana Stocks A Good Investment? 2 Pot Stocks To Watch This Week
Are You Ready To Invest In The Cannabis Industry?
Evoqua Water Technologies Corp Essential to U.S. Water Demands The new Joe Biden administration is expected to stoke major changes in U.S. domestic and foreign policies. Since the election, so-called Biden stocks—green energy, marijuana, and infrastructure—have surged, and we haven’t even seen any concrete policies from the administration yet.... Read more
Study Finds Cannabis May Not Negatively Impact Liver Transplant Patients | High Times Total 0 Share Read more
Further Research into Psilocybin Opens New Doors for Treatment

NEW YORK, Jan. 7, 2021 /PRNewswire/ — Among the popular fields of study for biotech companies in recent years are gene editing, tissue engineering and regeneration, nanobiotechnology and others.

Read more
Peter Thiel-backed psychedelics start-up targets schizophrenia ahead of IPO

LONDON — ATAI Life Science, a Peter Thiel-backed start-up, has taken a majority stake in Recognify, a company that is developing drugs to help treat schizophrenia.

Read more
Despite Losses, Canadian Cannabis CEOs Among Nation’s Highest-Paid Executives

Several Canadian cannabis company CEOs were among the highest paid corporate executives in the nation in 2019, according to a Centre for Policy Alternatives’ analysis titled “The Golden Cushion: CEO compensation in Canada.”

Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )